CLDN6 and esophageal squamous cell carcinoma: Both the TE-1-CLDN6 and the PDX models used in this study represent esophageal squamous cell carcinoma to ensure that the experimental design closely aligns with clinical characteristics, thereby enhancing the potential clinical translatability of our findings.